PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY

Detalles Bibliográficos
Autores principales: Pereira, M., Marques, G., Sarmento-Ribeiro, A.-B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430079/
http://dx.doi.org/10.1097/01.HS9.0000850200.50801.a5
_version_ 1784779649865220096
author Pereira, M.
Marques, G.
Sarmento-Ribeiro, A.-B.
author_facet Pereira, M.
Marques, G.
Sarmento-Ribeiro, A.-B.
author_sort Pereira, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9430079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94300792022-08-31 PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY Pereira, M. Marques, G. Sarmento-Ribeiro, A.-B. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430079/ http://dx.doi.org/10.1097/01.HS9.0000850200.50801.a5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Pereira, M.
Marques, G.
Sarmento-Ribeiro, A.-B.
PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
title PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
title_full PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
title_fullStr PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
title_full_unstemmed PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
title_short PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
title_sort pb1837: addition of a third, non-targeted, agent to cytarabine- and anthracycline-based induction chemotherapy for acute myeloblastic leukemia increases complete remissions and treatment-related mortality
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430079/
http://dx.doi.org/10.1097/01.HS9.0000850200.50801.a5
work_keys_str_mv AT pereiram pb1837additionofathirdnontargetedagenttocytarabineandanthracyclinebasedinductionchemotherapyforacutemyeloblasticleukemiaincreasescompleteremissionsandtreatmentrelatedmortality
AT marquesg pb1837additionofathirdnontargetedagenttocytarabineandanthracyclinebasedinductionchemotherapyforacutemyeloblasticleukemiaincreasescompleteremissionsandtreatmentrelatedmortality
AT sarmentoribeiroab pb1837additionofathirdnontargetedagenttocytarabineandanthracyclinebasedinductionchemotherapyforacutemyeloblasticleukemiaincreasescompleteremissionsandtreatmentrelatedmortality

Ejemplares similares